David M. Carr
Mr. Carr comes from a Cleveland family with a rich history in business success and social involvement. As President CEO of Brennan Industries, Mr. Carr has invested over 30 years in growing this industrial manufacturer from a local business into a multi-national corporation and strong global employer with 15 locations across the US, Europe and Asia. He and his company serve leading essential companies worldwide, such as Boeing, SpaceX, John Deere, Ingersoll Rand, Oshkosh, Toyota and many others.
Along with business acumen, Mr. Carr has a long history of social involvement ranging from philanthropy to board membership with significant organizations. A graduate of Hiram College in 1984, he now serves on the Board of Directors. He serves on the boards of several other venerable institutions including Fifth-Third Bank, The Young Scientist Foundation, and University Hospitals Cleveland Medical Center. Mr. Carr puts his significant leadership experience to work as Council to the Dean of the School of Medicine at Case Western Reserve University and on the Leadership Council of Ahuja Medical Center.
Giving back to the community is an important component of the Carr family legacy, and Dave has invested in the community through events including Cooking for a Cure and the Five Star Sensation Chef’s Classic, as well as through corporate initiatives with Toys for Tots, the Sub-Zero Mission, Community Food Banks, and many others.
Dave has been married to his wife Angela since 1994. Together they have three sons, Joseph, Michael and Justin, and reside in Hunting Valley, Ohio.
Jennifer Cullen, PhD, MPH
2023 Greater Cleveland Golf Classic Honorary Chair & Honoree
Dr. Cullen’s predominant research focus has been on the identification and validation of biomarkers and assay panels to forecast prostate cancer outcomes, with an emphasis on investigating racial disparities in disease outcomes and factors that influence quality of life trajectories for cancer survivors. For over a decade, she directed the scientific efforts for a longitudinal, racially diverse data repository of male military health care beneficiaries biopsied for prostate cancer, with detailed clinical annotation and follow-up information on 29,500+ men, as well as biospecimen collection on a large subset of these subjects. She has fostered productive extramural collaborations with both academic and industry partners, and has successfully obtained multiple peer-reviewed grants, including federal and industry-sponsored awards. A highlight of collaborative efforts with industry through a CRADA agreement was her leadership role in the validation study of the OncotypeDx® 17-gene panel assay for predicting prostate cancer progression (European Urology, 2015).
In 2020, Dr. Cullen became the Associate Director (AD) of Cancer Population Sciences at the Case Comprehensive Cancer Center and a Professor in the Department of Population and Quantitative Health Sciences at Case Western Reserve University School of Medicine. In these roles, she coordinates large team science projects and grants among cancer center members and leadership. She also engages Northeast Ohio community leaders in the ongoing scientific endeavors of the cancer center. Her current research efforts are focused on examination of the independent and joint roles of biological, social, and environmental determinants of cancer disparities for multiple malignancies, including novel statistical approaches to jointly consider the influence of neighborhood- and individual-level factors. She also teaches the Introductory Statistics course to the Master of Public Health students in her Department.
In a complementary role, Dr. Cullen has long-standing experience as a patient advocate through her participation in the Alliance for Childhood Cancer’s annual Advocacy Day on Capitol Hill in Washington, DC and as a Board Member of the American Childhood Cancer Organization, meeting with Congressional representatives to champion key pieces of legislation for bipartisan sponsorship, such as the “Childhood Cancer Survivorship, Treatment, Access, and Research” (STAR) Act (Public Law 115-180). Most recently, she offered testimony at Ohio’s State Capitol in support of a cancer biomarker testing bill introduced by the American Cancer Society’s Cancer Action Network. Additionally, she served as an invited speaker for a workshop jointly sponsored by the American Cancer Society and the Institute of Medicine, entitled “Comprehensive Cancer Care for Children and Their Families”, aimed at improving palliative care for childhood cancer patients and their families.
She is deeply committed to researching the continuum of cancer care, from prevention to survivorship and palliative care, especially among the most vulnerable cancer populations.